Akzo Nobel N.V.
AKZOF
$55.95
-$1.73-3.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 11.47B | 11.59B | 11.52B | 11.57B | 11.56B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.47B | 11.59B | 11.52B | 11.57B | 11.56B |
| Cost of Revenue | 6.86B | 6.89B | 6.82B | 6.84B | 6.85B |
| Gross Profit | 4.62B | 4.69B | 4.70B | 4.73B | 4.71B |
| SG&A Expenses | 3.35B | 3.35B | 3.31B | 3.29B | 3.25B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 6.54M | 6.57M | -17.10M | -73.75M | -68.32M |
| Total Operating Expenses | 10.53B | 10.56B | 10.40B | 10.35B | 10.32B |
| Operating Income | 942.82M | 1.02B | 1.12B | 1.22B | 1.24B |
| Income Before Tax | 813.29M | 909.01M | 915.40M | 963.85M | 961.37M |
| Income Tax Expenses | 255.10M | 266.47M | 256.33M | 276.17M | 334.50M |
| Earnings from Continuing Operations | 558.18 | 642.54 | 659.07 | 687.68 | 626.87 |
| Earnings from Discontinued Operations | 1.08M | -9.30K | -3.24M | -4.33M | -5.40M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -54.56M | -53.94M | -45.49M | -46.50M | -46.68M |
| Net Income | 504.70M | 588.59M | 610.34M | 636.85M | 574.78M |
| EBIT | 942.82M | 1.02B | 1.12B | 1.22B | 1.24B |
| EBITDA | 1.35B | 1.42B | 1.52B | 1.61B | 1.63B |
| EPS Basic | 2.96 | 3.45 | 3.58 | 3.73 | 3.37 |
| Normalized Basic EPS | 2.66 | 3.02 | 3.26 | 3.24 | 3.23 |
| EPS Diluted | 2.94 | 3.44 | 3.57 | 3.72 | 3.36 |
| Normalized Diluted EPS | 2.64 | 3.00 | 3.25 | 3.23 | 3.22 |
| Average Basic Shares Outstanding | 683.10M | 682.90M | 682.70M | 682.50M | 682.40M |
| Average Diluted Shares Outstanding | 689.86M | 688.03M | 683.87M | 684.11M | 684.01M |
| Dividend Per Share | 2.12 | 2.12 | 2.13 | 2.13 | 2.14 |
| Payout Ratio | 71.54% | 61.75% | 60.17% | 59.54% | 65.59% |